Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers
- PMID: 22921696
- DOI: 10.1016/j.urology.2012.06.034
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers
Abstract
Objective: To examine differences in 24-hour urine composition between recurrent and first-time stone-formers.
Methods: A retrospective review of patients evaluated in 2 metabolic stone clinics was performed. Recurrent stone formation was defined as patients with a history of more than 1 stone episode and first-time stone-formers were those with a history of a single-stone episode. Frequencies of urine metabolic abnormalities were noted. Multivariate linear regression was performed to evaluate the likelihood of abnormalities of 24-hour urine composition.
Results: Three-hundred eleven patients met inclusion criteria: 71 (22.8%) were first-time stone-formers and 240 (77.1%) were recurrent stone-formers. On univariate analysis, the likelihood of having a single abnormality of 24-hour urine composition (ie, hypercalciuria, hyperoxaluria, hyperuricosuria, or hypocitraturia) was similar between the 2 groups (83.1% for first-time vs 88.8% for recurrent, P = NS). In addition, there were similar rates of hypercalciuria (39.4% vs 43.3%, P = NS), hyperoxaluria (32.4% vs 33.3%, P = NS), hyperuricosuria (29.6% vs 23.3%, P = NS), and hypocitraturia (45.0% vs 45.0%, P = NS). On multivariate logistic regression, there was no difference in detection of any urine abnormality (ie, hypercalciuria or hyperoxaluria or hypocitraturia or hyperuricosuria) between first-time (referent) or recurrent stone-formers (OR 1.68, 95% CI .8-3.5, P = .2).
Conclusion: In this study, detection of urine abnormalities was similar in first-time and recurrent stone-formers. Given the strong patient preference for stone prevention and the high success of directed therapy in the literature, we believe it is not unreasonable to offer comprehensive metabolic evaluation to first-time stone-formers who express a desire to undergo evaluation.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment in
-
Re: radiation dose reduction at multidetector CT with adaptive statistical iterative reconstruction for evaluation of urolithiasis: how low can we go?J Urol. 2013 Apr;189(4):1360-1. doi: 10.1016/j.juro.2012.12.058. Epub 2012 Dec 22. J Urol. 2013. PMID: 23561352 No abstract available.
-
Re: abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.J Urol. 2013 Apr;189(4):1360. doi: 10.1016/j.juro.2012.12.035. Epub 2012 Dec 20. J Urol. 2013. PMID: 23561353 No abstract available.
Similar articles
-
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.J Endourol. 2017 Dec;31(12):1335-1341. doi: 10.1089/end.2017.0352. J Endourol. 2017. PMID: 29084490
-
Urinary risk factors for recurrent calcium stone formation in Thai stone formers.J Med Assoc Thai. 2007 Apr;90(4):688-98. J Med Assoc Thai. 2007. PMID: 17487123
-
Screening for biochemical abnormalities in urolithiasis patients.J Ayub Med Coll Abbottabad. 2004 Apr-Jun;16(2):60-3. J Ayub Med Coll Abbottabad. 2004. PMID: 15455621
-
Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.Scand J Urol. 2020 Dec;54(6):456-462. doi: 10.1080/21681805.2020.1840430. Epub 2020 Nov 13. Scand J Urol. 2020. PMID: 33185135
-
Challenges in the diagnostic and therapeutic approach to nephrolithiasis.Curr Opin Nephrol Hypertens. 2012 Mar;21(2):183-8. doi: 10.1097/MNH.0b013e3283501292. Curr Opin Nephrol Hypertens. 2012. PMID: 22257797 Review.
Cited by
-
Kidney stones.Nat Rev Dis Primers. 2016 Feb 25;2:16008. doi: 10.1038/nrdp.2016.8. Nat Rev Dis Primers. 2016. PMID: 27188687 Free PMC article. Review.
-
Fasting urinary calcium-to-creatinine and oxalate-to-creatinine ratios in dogs with calcium oxalate urolithiasis and breed-matched controls.J Vet Intern Med. 2015 Jan;29(1):113-9. doi: 10.1111/jvim.12527. Epub 2015 Jan 10. J Vet Intern Med. 2015. PMID: 25581880 Free PMC article.
-
UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.Can Urol Assoc J. 2022 Jun;16(6):175-188. doi: 10.5489/cuaj.7872. Can Urol Assoc J. 2022. PMID: 35623003 Free PMC article. No abstract available.
-
Update on the evaluation of repeated stone formers.Curr Urol Rep. 2013 Dec;14(6):549-56. doi: 10.1007/s11934-013-0347-4. Curr Urol Rep. 2013. PMID: 23749387
-
Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study.Urolithiasis. 2017 Dec;45(6):525-533. doi: 10.1007/s00240-016-0955-9. Epub 2016 Dec 9. Urolithiasis. 2017. PMID: 27942796
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous